LeonaBio (LONA) Other Operating Expenses (2023 - 2026)

LeonaBio (LONA) has 4 years of Other Operating Expenses data on file, last reported at -$17.2 million in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at -$17.2 million, down 125.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $63.9 million (down 6.15% YoY), and the FY2025 annual result was $68.1 million, changed N/A from the prior year.
• Other Operating Expenses declined to -$17.2 million in Q1 2026 per LONA's latest filing, from $86.4 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $86.4 million in Q4 2025 and troughed at -$24.8 million in Q1 2024.
• A 4-year average of $15.6 million and a median of -$5.2 million in 2025 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2024 and 2026: Other Operating Expenses soared 4636.81% in 2024, then slumped 125.31% in 2026.
• A 4-year view of Other Operating Expenses shows it stood at $1.6 million in 2023, then soared by 4636.81% to $75.8 million in 2024, then gained by 14.02% to $86.4 million in 2025, then sank by 119.96% to -$17.2 million in 2026.
• Business Quant data shows LONA's Other Operating Expenses at -$17.2 million in Q1 2026, $86.4 million in Q4 2025, and -$5.2 million in Q3 2025.